5 things you should know about Remdesivir

Scientists are examining dozens of drugs as possible treatments for coronavirus. But the fortunes of one — Gilead’s remdesivir — has moved global financial markets. As investors try to parse conflicting scientific evidence about remdesivir’s potential, here are some of the facts: What